Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 4 Open-market sale Director sold 32,300 shares at an average $2.33 ($75,240)
  2. 4 Open-market sale Director sold 6,400 shares at $2.23 ($14,273)
  3. 4 Grant or award Director acquired 35,500 shares (grant or award)
  4. 4 Grant or award Director acquired 35,500 shares (grant or award)
  5. 4 Grant or award Director acquired 35,500 shares (grant or award)
  6. 4 Grant or award Director acquired 35,500 shares (grant or award)
  7. 4 Grant or award Director acquired 35,500 shares (grant or award)
  8. 4 Grant or award Director acquired 35,500 shares (grant or award)
  9. 4 Grant or award Director acquired 35,500 shares (grant or award)
  10. 4 Grant or award Director acquired 35,500 shares (grant or award)
  11. 4 Grant or award Director acquired 6,060,606 shares (grant or award)
  12. 4 Planned sale Chief Legal Officer & Corp Sec sold 2,090 shares at $3.26 ($6,813)
  13. 4 Planned sale Chief Legal Officer & Corp Sec sold 9,406 shares at $3.01 ($28,311)
  14. 4 Planned sale Chief Legal Officer & Corp Sec sold 17,756 shares at an average $3.00 ($53,280)
  15. 4 Open-market sale Chief Legal Officer & Corp Sec sold 8,934 shares at an average $1.87 ($16,721)
  16. 4 Open-market sale Chief Medical Officer sold 3,226 shares at an average $1.81 ($5,833)
  17. 4 Open-market sale CFO & Chief Business Officer sold 4,160 shares at an average $1.83 ($7,607)
  18. 4 Open-market sale Chief Executive Officer sold 12,035 shares at an average $1.83 ($21,993)
  19. 4 Open-market sale Chief Operating Officer sold 2,777 shares at an average $1.81 ($5,031)
  20. 4 Grant or award Chief Executive Officer acquired 299,800 shares (grant or award)

Page 1 of 7 · 140 filings